KRAS and neoplasm: Moreover, we found that in the “Tumor Colon (KRAS mut)-Hase-59-MAS5.0-u133p2” data set (P = 0.096), and the “Tumor Colon CIT (Combat)-Marisa-566-rma-u133p2” data set (P = 0.076) the p-value was higher than 0.05 in R2, however the high expression of FBXW4 was associated with a better event and relapse-free survival than in the lower groups (Figures 5E, F).